MedPath
HSA Approval

APO-AMOXI CAPSULE 250 mg

SIN00213P

APO-AMOXI CAPSULE 250 mg

APO-AMOXI CAPSULE 250 mg

April 5, 1988

PHARMAFORTE SINGAPORE PTE LTD

PHARMAFORTE SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantPHARMAFORTE SINGAPORE PTE LTD
Licence HolderPHARMAFORTE SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

J01CA04

amoxicillin

Manufacturer Information

PHARMAFORTE SINGAPORE PTE LTD

APO-BIOTICS LIMITED

Active Ingredients

AMOXYCILLIN TRIHYDRATE EQV AMOXYCILLIN

250 mg

Amoxicillin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

APO-AMOXI CAPSULE 250 mg - HSA Approval | MedPath